Doximity (DOCS) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.36
- Estimate
- $0.35
- Surprise
- +2.8%
- Revenue (period 2026-09-30)
- $174.5M
- Score today
- 5.1/10
Revenue source: xbrl.
How the report landed
Doximity (DOCS) beat the $0.35 estimate with adjusted EPS of $0.36 — a modest 2.8% upside surprise.
Coverage in the report window
- Doximity Stock Slips on Q2 Earnings: Key Details — benzinga, 2026-11-05
Where TrendMatrix's rating stands now
TrendMatrix currently rates DOCS Hold at 5.1/10; no pre/post engine snapshot brackets this report.
2 of the last 4 quarters beat the estimate; this quarter's +2.8% surprise compares with a -1.6% four-quarter average.
What supports the rating
- V7 flight-to-quality bonus: +0.5 (Q=8.2 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Analyst target reached - limited upside remaining
- Consecutive earnings misses (2)
- Weak growth
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $32.44
- Stop
- $30.17
The stock trades at 39.0× trailing but 21.3× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-11-06 — shown for context, not personalized investment advice.
DOCS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Health Information Services
- Market cap
- $5.91B
- P/E (fwd)
- 21.3
- P/E (ttm)
- 39.0
- 52-week range
- $17.15–$64.55
- Off 52-week high
- 49.7%
- RSI (14)
- 55
- Volume vs avg
- 0.74×
- Score today
- 5.1/10